SLIDE 7 Contraception Access During Health Care Engagement
- Immediate postpartum period
– Fewer insurance barriers – Safe and effective – Reduces risk of rapid repeat pregnancy – Continuation rates are similar to insertions at other times
- Association of State and Territorial Health Care Officials
(ASTHO) and CDC partnered with states to understand barriers to policy implementation for systems change
Hathaway, M., Torres, L., Vollett-Krech, J., & Wohltjen, H. (2014). Increasing LARC utilization: any woman, any place, any time. Clin Obstet Gynecol, 57(4), 718-730. Curtis, K. M., Tepper, N. K., Jatlaoui, T. C., Berry-Bibee, E., Horton, L. G., Zapata, L. B., . . . Whiteman, M. K. (2016). U.S. Medical Eligibility Criteria for Contraceptive Use,
- 2016. MMWR Recomm Rep, 65(3), 1-103.
Thiel de Bocanegra, H., Chang, R., Howell, M., & Darney, P. (2014). Interpregnancy intervals: impact of postpartum contraceptive effectiveness and coverage. Am J Obstet Gynecol, 210(4), 311 e311-318. Woo, I., Seifert, S., Hendricks, D., Jamshidi, R. M., Burke, A. E., & Fox, M. C. (2015). Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices. Contraception, 92(6), 532-535.